However, by slightly altering the chemical structure of this nutrient (adding the acetyl group), it can cross the blood-brain barrier and function to support both brain health and energy production
This option is convenient for patients
Mallampalli, PhD, is CEO of ASAP
Key Market Trends to Watch Through 2035 Several trends are expected to shape the future of the GLP-1 industry: Rapid growth of oral GLP-1 drugs Expansion into cardiovascular and neurological indications Development of triple-agonist therapies Increased use of AI-driven drug discovery Greater telehealth integration Growth of biosimilars in emerging markets Employer-sponsored weight management programs Personalized obesity treatment approaches Together, these trends could redefine the future of chronic disease management
Those changes dont go away with time
The expanded RoenRx weight loss program integrates medical evaluation, treatment access, insurance navigation, and ongoing monitoring into a single digital-first care experience designed to support patients seeking long-term weight management and improved metabolic health